TFX vs UTMD

For growth investors, Utah Medical Products, Inc.

(UTMD) is the stronger pick with -5. 8% revenue growth year-over-year, versus -34. 6% for Teleflex Incorporated (TFX). Utah Medical Products, Inc. (UTMD) offers the better valuation at 18. 8x trailing P/E (10. 4x forward), making it the more compelling value choice. Analysts rate Teleflex Incorporated (TFX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Utah Medical Products, Inc.

is actually cheaper at 10. 4x.

Over the past 5 years, Utah Medical Products, Inc.

(UTMD) delivered a total return of -18. 2%, compared to -66. 4% for Teleflex Incorporated (TFX). Over 10 years, the gap is even starker: UTMD returned +19. 1% versus TFX's -10. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Utah Medical Products, Inc.

(UTMD) is the lower-risk stock at 0. 55β versus Teleflex Incorporated's 1. 06β — meaning TFX is approximately 91% more volatile than UTMD relative to the S&P 500. On balance sheet safety, Utah Medical Products, Inc. (UTMD) carries a lower debt/equity ratio of 0% versus 87% for Teleflex Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Utah Medical Products, Inc.

(UTMD) is pulling ahead at -5. 8% versus -34. 6% for Teleflex Incorporated (TFX). On earnings-per-share growth, the picture is similar: Utah Medical Products, Inc. grew EPS -12. 1% year-over-year, compared to -1468. 2% for Teleflex Incorporated. Over a 3-year CAGR, UTMD leads at -9. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Utah Medical Products, Inc.

(UTMD) is the more profitable company, earning 29. 3% net margin versus -45. 4% for Teleflex Incorporated — meaning it keeps 29. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UTMD leads at 29. 6% versus 12. 8% for TFX. At the gross margin level — before operating expenses — TFX leads at 56. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Utah Medical Products, Inc.

(UTMD) trades at 10. 4x forward P/E versus 19. 6x for Teleflex Incorporated — 9. 2x cheaper on a one-year earnings basis.

All stocks in this comparison pay dividends.

Utah Medical Products, Inc. (UTMD) offers the highest yield at 1. 9%, versus 1. 0% for Teleflex Incorporated (TFX).

For long-horizon retirement investors, Utah Medical Products, Inc.

(UTMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 55), 1. 9% yield). Both have compounded well over 10 years (UTMD: +19. 1%, TFX: -10. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.